Welcome!

News Feed Item

American Diabetes Association Announces Requests for Applications for Research Collaboration With Boehringer Ingelheim

Awards Will Focus on Chronic Kidney Disease and Renal Insufficiency in Diabetes

ALEXANDRIA, VA -- (Marketwired) -- 06/02/14 -- The American Diabetes Association (Association) is pleased to announce the opening of a request for applications today for The American Diabetes Association and Boehringer Ingelheim Research Award: Chronic Kidney Disease and Renal Insufficiency in the Setting of Diabetes, a three-year program which will fund research that focuses on improving the clinical care of people with chronic kidney disease and diabetes. The program is made possible through $1.5 million in funding from Boehringer Ingelheim and is directed, managed and overseen by the Association.

This research effort follows recommendations from a recent American Diabetes Association Consensus Conference: "Chronic Kidney Disease and Diabetes" on the current status of care for people with diabetes and chronic kidney disease (CKD). This important conference was held in collaboration with the American Society of Nephrology (ASN) and the National Kidney Foundation (NKF). A number of critical research gaps were identified, and this initiative aims to address some of these important questions in order to improve care for people with chronic kidney disease and diabetes. Diabetes is the leading cause of kidney failure, accounting for more than 40 percent of new cases, and renal insufficiency complicates the care of people with diabetes.

"The American Diabetes Association is excited to open the call for applications for The American Diabetes Association and Boehringer Ingelheim Award: Chronic Kidney Disease and Renal Insufficiency in the Setting of Diabetes research grants," said Elizabeth R. Seaquist, MD, President, Medicine & Science, American Diabetes Association. "Chronic kidney disease is a serious complication for people who are living with diabetes. This research is critical in allowing us to better understand the connection between the two diseases, and to explore more effective ways that we can manage them medically, allowing people with diabetes to lead healthier lives."

The grants will fund a wide range of research, including:

  • Studies aimed at validation and standardization of established markers of CKD (albuminuria, UACR, eGFR, GFR), and identification and validation of non-traditional/novel biomarkers of CKD in people with diabetes, with the intent to improve diagnosis and disease characterization, identify progressors and non-progressors, and monitor treatment responses.

  • Investigation of the mechanisms underlying the development of microvascular kidney disease to identify targets for the development of novel therapeutic approaches; particularly systems biology approaches (metabolomics, functional genomics, proteomics, etc.) to elucidate novel factors and pathways that impact kidney function and the development of chronic kidney disease in diabetes.

  • Translational studies examining clinical efficacy of novel candidates for treatment of microvascular kidney disease; including studies utilizing non-traditional biomarkers or surrogate endpoints to detect early signals of potential benefit and to inform drug development decision making.

  • Comparative effectiveness studies examining the effects of different pharmacological treatment strategies on glycemic control, lipids, blood pressure, and other cardiovascular risk factors in patients with diabetes at various stages of CKD, up to and including ESRD/dialysis.

  • Epidemiological, database or clinical studies examining the rates and consequences of hypoglycemia in people with diabetic kidney disease, identifying people at highest risk for hypoglycemia and optimal treatment strategies for patients with diabetes and CKD who are at high risk for hypoglycemia.

"Boehringer Ingelheim is looking forward to high-quality proposals for this research collaboration with the American Diabetes Association which aims to close some of the important scientific gaps identified by the Consensus Conference: 'Chronic Kidney Disease and Diabetes,'" said Hans-Jürgen Wörle, Vice President, Therapeutic Area Medicine Metabolism, Boehringer Ingelheim.

To learn more, visit www.diabetes.org/grants. The request for applications will be open until September 15, 2014.

Throughout the years, the Association has funded innovative and groundbreaking diabetes research and has invested approximately $675 million in more than 4,000 research projects. The Association's research allows people to lead healthier and more productive lives every day.

The American Diabetes Association is leading the fight to Stop Diabetes® and its deadly consequences and fighting for those affected by diabetes. The Association funds research to prevent, cure, and manage diabetes; delivers services to hundreds of communities; provides objective and credible information; and gives voice to those denied their rights because of diabetes. Founded in 1940, our mission is to prevent and cure diabetes and to improve the lives of all people affected by diabetes. For more information please call the American Diabetes Association at 1-800-DIABETES (1-800-342-2383) or visit www.diabetes.org. Information from both these sources is available in English and Spanish.

Contact:

Lauren Gleason
(703) 549-1500 ext. 2622
[email protected]

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.

Latest Stories
DevOps at Cloud Expo, taking place October 31 - November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA, is co-located with 21st Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry players in the world. The widespread success of cloud computing is driving the DevOps revolution in enterprise IT. Now as never before, development teams must communicate and collaborate in a dynamic, 24/7/365 environment. There is no time to w...
SYS-CON Events announced today that Daiya Industry will exhibit at the Japanese Pavilion at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Ruby Development Inc. builds new services in short period of time and provides a continuous support of those services based on Ruby on Rails. For more information, please visit https://github.com/RubyDevInc.
When it comes to cloud computing, the ability to turn massive amounts of compute cores on and off on demand sounds attractive to IT staff, who need to manage peaks and valleys in user activity. With cloud bursting, the majority of the data can stay on premises while tapping into compute from public cloud providers, reducing risk and minimizing need to move large files. In his session at 18th Cloud Expo, Scott Jeschonek, Director of Product Management at Avere Systems, discussed the IT and busine...
As businesses evolve, they need technology that is simple to help them succeed today and flexible enough to help them build for tomorrow. Chrome is fit for the workplace of the future — providing a secure, consistent user experience across a range of devices that can be used anywhere. In her session at 21st Cloud Expo, Vidya Nagarajan, a Senior Product Manager at Google, will take a look at various options as to how ChromeOS can be leveraged to interact with people on the devices, and formats th...
First generation hyperconverged solutions have taken the data center by storm, rapidly proliferating in pockets everywhere to provide further consolidation of floor space and workloads. These first generation solutions are not without challenges, however. In his session at 21st Cloud Expo, Wes Talbert, a Principal Architect and results-driven enterprise sales leader at NetApp, will discuss how the HCI solution of tomorrow will integrate with the public cloud to deliver a quality hybrid cloud e...
Is advanced scheduling in Kubernetes achievable? Yes, however, how do you properly accommodate every real-life scenario that a Kubernetes user might encounter? How do you leverage advanced scheduling techniques to shape and describe each scenario in easy-to-use rules and configurations? In his session at @DevOpsSummit at 21st Cloud Expo, Oleg Chunikhin, CTO at Kublr, will answer these questions and demonstrate techniques for implementing advanced scheduling. For example, using spot instances ...
SYS-CON Events announced today that Yuasa System will exhibit at the Japan External Trade Organization (JETRO) Pavilion at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Yuasa System is introducing a multi-purpose endurance testing system for flexible displays, OLED devices, flexible substrates, flat cables, and films in smartphones, wearables, automobiles, and healthcare.
SYS-CON Events announced today that Taica will exhibit at the Japan External Trade Organization (JETRO) Pavilion at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Taica manufacturers Alpha-GEL brand silicone components and materials, which maintain outstanding performance over a wide temperature range -40C to +200C. For more information, visit http://www.taica.co.jp/english/.
As hybrid cloud becomes the de-facto standard mode of operation for most enterprises, new challenges arise on how to efficiently and economically share data across environments. In his session at 21st Cloud Expo, Dr. Allon Cohen, VP of Product at Elastifile, will explore new techniques and best practices that help enterprise IT benefit from the advantages of hybrid cloud environments by enabling data availability for both legacy enterprise and cloud-native mission critical applications. By rev...
When it comes to cloud computing, the ability to turn massive amounts of compute cores on and off on demand sounds attractive to IT staff, who need to manage peaks and valleys in user activity. With cloud bursting, the majority of the data can stay on premises while tapping into compute from public cloud providers, reducing risk and minimizing need to move large files. In his session at 18th Cloud Expo, Scott Jeschonek, Director of Product Management at Avere Systems, discussed the IT and busine...
Organizations do not need a Big Data strategy; they need a business strategy that incorporates Big Data. Most organizations lack a road map for using Big Data to optimize key business processes, deliver a differentiated customer experience, or uncover new business opportunities. They do not understand what’s possible with respect to integrating Big Data into the business model.
Companies are harnessing data in ways we once associated with science fiction. Analysts have access to a plethora of visualization and reporting tools, but considering the vast amount of data businesses collect and limitations of CPUs, end users are forced to design their structures and systems with limitations. Until now. As the cloud toolkit to analyze data has evolved, GPUs have stepped in to massively parallel SQL, visualization and machine learning.
Recently, REAN Cloud built a digital concierge for a North Carolina hospital that had observed that most patient call button questions were repetitive. In addition, the paper-based process used to measure patient health metrics was laborious, not in real-time and sometimes error-prone. In their session at 21st Cloud Expo, Sean Finnerty, Executive Director, Practice Lead, Health Care & Life Science at REAN Cloud, and Dr. S.P.T. Krishnan, Principal Architect at REAN Cloud, will discuss how they b...
Enterprises have taken advantage of IoT to achieve important revenue and cost advantages. What is less apparent is how incumbent enterprises operating at scale have, following success with IoT, built analytic, operations management and software development capabilities – ranging from autonomous vehicles to manageable robotics installations. They have embraced these capabilities as if they were Silicon Valley startups. As a result, many firms employ new business models that place enormous impor...
The next XaaS is CICDaaS. Why? Because CICD saves developers a huge amount of time. CD is an especially great option for projects that require multiple and frequent contributions to be integrated. But… securing CICD best practices is an emerging, essential, yet little understood practice for DevOps teams and their Cloud Service Providers. The only way to get CICD to work in a highly secure environment takes collaboration, patience and persistence. Building CICD in the cloud requires rigorous a...